These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 1381518

  • 41. Anti-CTLA-4 antibody treatment triggers determinant spreading and enhances murine myasthenia gravis.
    Wang HB, Shi FD, Li H, Chambers BJ, Link H, Ljunggren HG.
    J Immunol; 2001 May 15; 166(10):6430-6. PubMed ID: 11342669
    [Abstract] [Full Text] [Related]

  • 42. Early-onset myasthenia gravis: a recurring T-cell epitope in the adult-specific acetylcholine receptor epsilon subunit presented by the susceptibility allele HLA-DR52a.
    Hill M, Beeson D, Moss P, Jacobson L, Bond A, Corlett L, Newsom-Davis J, Vincent A, Willcox N.
    Ann Neurol; 1999 Feb 15; 45(2):224-31. PubMed ID: 9989625
    [Abstract] [Full Text] [Related]

  • 43. Highly conserved TCR beta chain CDR3 sequences among immunodominant acetylcholine receptor-reactive T cells in murine myasthenia gravis.
    Pierce JL, Zborowski KA, Kraig E, Infante AJ.
    Int Immunol; 1994 May 15; 6(5):775-83. PubMed ID: 8080845
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. T helper cell recognition of muscle acetylcholine receptor in myasthenia gravis. Epitopes on the gamma and delta subunits.
    Manfredi AA, Protti MP, Dalton MW, Howard JF, Conti-Tronconi BM.
    J Clin Invest; 1993 Aug 15; 92(2):1055-67. PubMed ID: 7688757
    [Abstract] [Full Text] [Related]

  • 46. Antigen presentation and T cell specificity repertoire in determining responsiveness to an epitope important in experimental autoimmune myasthenia gravis.
    Zoda TE, Krolick KA.
    J Neuroimmunol; 1993 Mar 15; 43(1-2):131-8. PubMed ID: 7681444
    [Abstract] [Full Text] [Related]

  • 47. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis.
    Yoshikawa H, Lambert EH, Walser-Kuntz DR, Yasukawa Y, McCormick DJ, Lennon VA.
    J Immunol; 1997 Aug 01; 159(3):1570-7. PubMed ID: 9233656
    [Abstract] [Full Text] [Related]

  • 48. Schwann cells and myasthenia gravis. Preferential uptake of soluble and membrane-bound AChR by normal and immortalized Schwann cells, and immunogenic presentation to AChR-specific T line lymphocytes.
    Zhang YP, Porter S, Wekerle H.
    Am J Pathol; 1990 Jan 01; 136(1):111-22. PubMed ID: 1688688
    [Abstract] [Full Text] [Related]

  • 49. Myasthenia gravis patients, but not healthy subjects, recognize epitopes that are unique to the epsilon-subunit of the acetylcholine receptor.
    Ragheb S, Mohamed M, Lisak RP.
    J Neuroimmunol; 2005 Feb 01; 159(1-2):137-45. PubMed ID: 15652413
    [Abstract] [Full Text] [Related]

  • 50. Modulation of anti-acetylcholine receptor antibody specificities and of experimental autoimmune myasthenia gravis by synthetic peptides.
    Souroujon MC, Carmon S, Fuchs S.
    Immunol Lett; 1992 Sep 01; 34(1):19-25. PubMed ID: 1282497
    [Abstract] [Full Text] [Related]

  • 51. Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides.
    Atassi MZ, Oshima M.
    Crit Rev Immunol; 1997 Sep 01; 17(5-6):481-95. PubMed ID: 9419435
    [Abstract] [Full Text] [Related]

  • 52. Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis.
    Poëa-Guyon S, Christadoss P, Le Panse R, Guyon T, De Baets M, Wakkach A, Bidault J, Tzartos S, Berrih-Aknin S.
    J Immunol; 2005 May 15; 174(10):5941-9. PubMed ID: 15879086
    [Abstract] [Full Text] [Related]

  • 53. Reactivity of T cells from seronegative patients with myasthenia gravis to T cell epitopes of the human acetylcholine receptor.
    Karni A, Zisman E, Katz-Levy Y, Paas-Rozner M, Dayan M, Brautbar C, Abramsky O, Sela M, Mozes E.
    Neurology; 1997 Jun 15; 48(6):1638-42. PubMed ID: 9191780
    [Abstract] [Full Text] [Related]

  • 54. T cells in myasthenia gravis specific for embryonic acetylcholine receptor.
    Protti MP, Manfredi AA, Howard JF, Conti-Tronconi BM.
    Neurology; 1991 Nov 15; 41(11):1809-14. PubMed ID: 1682852
    [Abstract] [Full Text] [Related]

  • 55. Proteins with epitopes of the acetylcholine receptor in epithelial cell cultures of thymomas in myasthenia gravis.
    Marx A, Kirchner T, Hoppe F, O'Connor R, Schalke B, Tzartos S, Müller-Hermelink HK.
    Am J Pathol; 1989 Apr 15; 134(4):865-77. PubMed ID: 2468286
    [Abstract] [Full Text] [Related]

  • 56. TCR gene usage in experimental autoimmune myasthenia gravis pathogenesis. Usage of multiple TCRBV genes in the H-2b strains.
    Wu B, Shenoy M, Goluszko E, Kaul R, Christadoss P.
    J Immunol; 1995 Apr 01; 154(7):3603-10. PubMed ID: 7897239
    [Abstract] [Full Text] [Related]

  • 57. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor.
    Bellone M, Ostlie N, Lei SJ, Wu XD, Conti-Tronconi BM.
    J Immunol; 1991 Sep 01; 147(5):1484-91. PubMed ID: 1715360
    [Abstract] [Full Text] [Related]

  • 58. T-cell antigenic sites involved in myasthenia gravis: correlations with antibody titre and disease severity.
    Berrih-Aknin S, Cohen-Kaminsky S, Lepage V, Neumann D, Bach JF, Fuchs S.
    J Autoimmun; 1991 Feb 01; 4(1):137-53. PubMed ID: 2031657
    [Abstract] [Full Text] [Related]

  • 59. MHC class II presentation of human acetylcholine receptor in Myasthenia gravis: binding of synthetic gamma subunit sequences to DR molecules.
    Yuen MH, Macklin KD, Conti-Fine BM.
    J Autoimmun; 1996 Feb 01; 9(1):67-77. PubMed ID: 8845056
    [Abstract] [Full Text] [Related]

  • 60. Specific immunotherapeutic strategy for myasthenia gravis: targeted antigen-presenting cells.
    Reim J, McIntosh K, Martin S, Drachman DB.
    J Neuroimmunol; 1992 Nov 01; 41(1):61-70. PubMed ID: 1460093
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.